Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering
Проливая свет на биогенез и биоинженерию внеклеточных везикул
2020-11-27
SCID: 54.1/mfk8fvsv
Discuss with AI
EV bioengineeringEV biogenesisclinical translationdrug delivery systemsextracellular vesicles
Figures from the paper
Abstract (AI)
Extracellular vesicles (EVs) are biocompatible, nano-sized secreted vesicles containing many types of biomolecules, including proteins, RNAs, DNAs, lipids, and metabolites. Their low immunogenicity and ability to functionally modify recipient cells by transferring diverse bioactive constituents make them an excellent candidate for a next-generation drug delivery system. Here, the recent advances in EV biology and emerging strategies of EV bioengineering are summarized, and the prospects for clinical translation of bioengineered EVs and the challenges to be overcome are discussed.
Key Findings
1
Clinical translation of bioengineered EVs remains dependent on overcoming unresolved challenges discussed in the review.
2
EVs exhibit low immunogenicity and can functionally modify recipient cells by transferring diverse bioactive constituents.
3
Extracellular vesicles are nano-sized, biocompatible carriers containing proteins, RNAs, DNAs, lipids, and metabolites.
4
Recent advances address EV biogenesis and bioengineering strategies aimed at improving their therapeutic and clinical translation potential.
5
These properties position EVs as promising candidates for next-generation drug delivery systems.
Research Object
extracellular vesicles (EVs)
Research Subject
EV biogenesis, biology, bioengineering strategies, and prospects and challenges for clinical translation
Publication Details
Publication Date
2020-11-27
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest